Prospective evaluation of echocardiography and serum biomarkers as predictors of cardiotoxicity in patients with breast cancer treated with anthracyclines, taxanes, with/without trastuzumab.
J. Soler Lopez(Fundación Hospital Provincial de Castellón), Angel Solloso, Candela Rodriguez, Ana Peset, Leticia De avila, Angela Lopez-Rodriguez(Fundación Hospital Provincial de Castellón), Javier Munárriz(Fundación Hospital Provincial de Castellón), María De Julián, María José Domper-Arnal(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Eduardo Martínez-De Dueñas, Alejandro Cortell, S. Olmos
Cited by 3
Related Papers
Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries
|World Journal of Gastroenterology|2015|1k
Gastrointestinal and cardiovascular adverse events associated with NSAIDs
|Expert Opinion on Drug Safety|2021|134
The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients
|Therapeutic Advances in Gastroenterology|2022|21